title: HLA-A2 subtype in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.
authors.forename: S
authors.initials: S
authors.lastname: Kakizaki
authors.forename: H
authors.initials: H
authors.lastname: Takagi
authors.forename: M
authors.initials: M
authors.lastname: Murakami
authors.forename: H
authors.initials: H
authors.lastname: Takayama
authors.forename: K
authors.initials: K
authors.lastname: Sato
authors.forename: M
authors.initials: M
authors.lastname: Mori
mesh_terms: D000483:Alleles; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000150:complications / Q000235:genetics* / Q000276:immunology; D005838:Genotype; D015789:HLA-A2 Antigen / Q000235:genetics* / Q000276:immunology; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000276:immunology / Q000494:pharmacology* / Q000627:therapeutic use; D016017:Odds Ratio; D013959:Thyroid Diseases / Q000139:chemically induced* / Q000150:complications / Q000235:genetics* / Q000276:immunology
chemical_list: D015789:HLA-A2 Antigen; D016898:Interferon-alpha